Health2 months ago
Focus Partners Expands Stake in Alnylam Pharmaceuticals by 533%
Focus Partners Advisor Solutions LLC has significantly increased its investment in Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by an impressive 533% during the third quarter of 2023....